Product Information
XELJANZ 5 MG TABLET is a brand product labeled by Pfizer Inc., priced at $73.6658 per EA under NDC 00069100101. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 6, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Pfizer Inc.NDC
00069100101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOFACITINIB CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA203214FDA Approved
11/6/2012
TE Code
AB
On Market Since
11/9/2012
Pharmacological Classes
Price Statistics
The NADAC for XELJANZ 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 121.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.6658 per EA |
|---|---|
| All-time high | $98.5905 (Jun 11, 2025) |
| All-time low | $33.2872 (Nov 28, 2013) |
| 52-week high | $98.4538 |
| 52-week low | $73.5726 |
| Median price | $73.7322 |
| Average price | $71.0626 |
| Largest weekly change | -25.0% (Dec 31, 2025) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tofacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XELJANZ 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XELJANZ 5 MG TABLET, manufactured by Pfizer Inc., is $73.6658 per EA (NDC 00069100101), effective Aug 19, 2026.
How has the price of XELJANZ 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for XELJANZ 5 MG TABLET has risen 121.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for XELJANZ 5 MG TABLET?
Since Nov 28, 2013, the NADAC for XELJANZ 5 MG TABLET has ranged from a low of $33.2872 (Nov 28, 2013) to a high of $98.5905 (Jun 11, 2025), with a median of $73.7322 per EA.
Are there cheaper alternatives to XELJANZ 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of XELJANZ 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XELJANZ 5 MG TABLET?
XELJANZ 5 MG TABLET (NDC 00069100101) is labeled by Pfizer Inc., and CMS classifies it as a brand product.